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The  decoctions  of  the  Butea  monosperma  (Lam.)  Taub.,  Fabaceae,  Bauhinia  variegata  L., Fabaceae,  and
Ocimum  gratissimum  L., Lamiaceae,  are  traditionally  used  for  the  treatment  of various  types  of  hepatic
disorder.  Phytochemical  studies  have  shown  that  total  ﬂavonoids  from  these  plants  were  the  major
constituents  of  the picked  out part  of  each  plant.  The  present  study  was  planned  to  investigate  the hep-
atoprotective  effect  of  ﬂavonoid  rich  fractions  of  the  B. monosperma,  B.  variegata  and  O.  gratissimum
against  paracetamol  induced  liver  damage.  Flavonoid  rich  fractions  were  isolated  by solvent  fraction-
ation  from  each  plant.  Each  fraction  was  subjected  to various  qualitative  chemical  tests to  ﬁndout  the
metabolites.  Flavonoid  fractions  of each  plant  were  subjected  for  pharmacological  screening.  The rats
were  monitored  for  change  in  liver  morphology,  biochemical  parameters  like  serum  glutamate  pyruvate
transaminase,  serum  glutamate  oxaloacetate  transaminase,  alkaline  phosphatase  and  total  bilirubin  for
the  groups  receiving  the  ﬂavonoid-rich  fractions.  All  ﬂavonoid  rich  fractions  showed  signiﬁcant  hep-
atoprotective  activity.  The  histological  studies  supported  the  biochemical  parameters.  From  the  results
of  biochemical  analysis  and  histopathological  studies,  it can be  accomplished  that  in the  ethyl  acetate
fraction  of O. gratissimum  showed  highest  hepatoprotective  activity  as compared  to  other  fractions.  The
present  study  was  the  ﬁrst  evidence  of  ﬂavonoid-rich  fractions  of each  plant  have a remarkable  hepato-
protective  effect.  All fractions  contain  a  potent  hepatoprotective  agent  suggested  to  be a ﬂavone,  which
may  ﬁnd  clinical  application  in amelioration  of  paracetamol-induced  liver  damage.
©  2015 Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.ntroduction
Liver diseases remain one of the serious health problems
Baranisrinivasan et al., 2009). Modern medications have little role
o alleviation of hepatic disease and the plant-based preparations
hich are chieﬂy available medicines employed for the treatment
f liver disorders (Raju et al., 2008). The strength of these plant
roducts must be established, thus as to identify newer medica-
ents acting against hepatic injury. In the absence of a reliable liver
rotective drug in the modern system of medication, a number of
edicinal plants in Ayurveda are recommended for the treatment
f liver disorders. Natural treatments from medicinal plants are
hought to be efﬁcacious and safe medicaments for hepatotoxicity.
Butea monosperma (Lam.) Taub. (BM) belongs to family Fabaceae
s a medium size deciduous tree, found throughout India and
∗ Corresponding author.
E-mail: arti.gupta@utu.ac.in (A. Gupta).
http://dx.doi.org/10.1016/j.bjp.2015.06.010
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoratraditionally used for the treatment of hepatopathy, ulcers, tumors,
and diabetes (Kirtikar et al., 1999). The plant mainly contains
ﬂavones (quercetin) (Nadkarni, 1994; Gupta et al., 2013a), kino-
tannic acid and gallic acid.
Bauhinia variegata L. (BV) belongs to the family Fabaceae com-
monly known as Kachnar, is found to be beneﬁcial in Ayurveda
as a tonic to the liver and anti-inﬂammatory, healing activity,
antioxidant activity (Bodakhe and Ram, 2007). It has been reported
to contain quercetin, rutin, apigenin and apigenin 7-O-glucoside.
Flavonoids and quercetin in particular are strong antioxidants and
are known to regulate the activities of various enzyme systems due
to their interaction with various biomolecules (Maldonado et al.,
2003).
Ocimum gratissimum L. (OG) belongs to family Lamiaceae is an
erect, multi-branched perennial shrub that grows up to a height
of two meters with a tap root and many adventitious rootlets
(Ramachandran et al., 1986). Essential oils obtained from Ocimum
species showed various medicinal potentials in chemo-preventive,
anti-carcinogenic, free radical scavenging, and radio-protective
 Ltda. All rights reserved.
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ses (Gupta et al., 2002; Onajobi, 1986; Prakash and Gupta, 2000).
dditionally, OG leaf also revealed signiﬁcant chemo-preventive
ffects on chemical-induced papilloma genesis by modulating
etabolizing enzymes such as cytochrome P450, glutathione-S-
ransferase, and aryl hydrocarbon hydroxylase (Karthikeyan et al.,
999; Prashar et al., 1994). A recent study indicated that admin-
stered orally aqueous extract of OG leaf could oxidative and
oxicant activity and enhance speciﬁc activities of hepatic antioxi-
ant enzymes in rats (Ighodaro and Ebuehi, 2008). Notably, recent
tudy also showed that the OG leaf aqueous extract (OGAE) may  be
mportant in protecting H9c2 cells from H2O2-induced cell death
y inhibiting the mitochondrial dependent apoptosis pathway (Lee
t al., 2010). Epicatechin, caffeic acid, rutin, gallic acid, quercetin,
pigallocatechin gallate were identiﬁed as major components of
henolic acids and ﬂavonoids in OGAE (Chiu et al., 2012; Grayer
t al., 2000). Ursolic acid was determined in dichloromethane and
thyl acetate fractions of methanolic extract of O. gratissimum in
reviously published report (Gupta et al., 2013b).
The ﬂavonoid, quercetin in acetone fraction of B. monosperma,
thyl acetate and n-butanol fractions of B. variegata;
ichloromethane and ethyl acetate fractions of O. gratissimum
ere identiﬁed in previously published report (Gupta et al., 2013a).
Quercetin (ﬂavonoid) and ursolic acid (triterpenic acid) are well
nown for its hepatoprotective effects in acute chemically induced
iver injury and chronic liver ﬁbrosis and cirrhosis (Janbaz et al.,
004).
Although these studies strongly implicated the medicinal effects
f the above plants, there is no study for the beneﬁcial effects of
avonoid rich fractions of these plants on paracetamol-induced
epatic injury. Therefore, in order to fully develop the medical
lant resources and to justify the use of this preparation in tra-
itional medicine for the treatment of liver complaint, the present
tudy was designed to investigate the hepatoprotective effect of
he ﬂavonoid-rich fractions obtained from different parts of B.
onosperma, B. variegate and O. gratissimum against paracetamol-
nduced liver injury in vivo.
aterials and methods
nimals
Albino Wistarmale rats (125–175 g) were used for determi-
ation of maximum tolerable dose (MTD) and evaluation of
epatoprotective activity. The animals were housed in polypropyl-
ne cages at 25 ± 1 ◦C with the relative humidity of 55 ± 5% under
2/12 h light/dark cycles. They were received standard chow and
ater during experimentation. The food was withdrawn on the day
efore the experiment, but free access of water was  allowed.
A minimum of six animals was used in each group. Throughout
he experiment, animals were treated according to the suggested
nternational ethical guidelines for the maintenance of laboratory
nimals. The study protocol was approved by the Institutional
nimal Ethics Committee, according to the regulation of the Com-
ittee for the Purpose of Control and Supervision of Experiments
n Animals (MPC 1007: dated: 30/01/2010).
lant materials
The fresh bark of Butea monosperma (Lam.) Taub., Fabaceae (BM),
auhinia variegate L., Fabaceae (BV) and fresh leaves of Ocimum
ratissimum L., Lamiaceae (OG) were collected from the cam-
us of Maliba pharmacy college, Bardoli. Voucher specimen (No:
PC/13032010/01, 2 and 03) has been deposited in the Department
f Bioscience, Veer Narmad South Gujarat University, Surat, India.
ats were used for hepatoprotective study, with prior approvalmacognosia 25 (2015) 485–490
from the Institutional Animal Ethical Committee (Registration No.
717/02/a/CPCSEA/30 Jan 2010) of Maliba Pharmacy College, Uka
Tarsadia University.
Extraction and fractionation procedures
The dried and powdered material of each plant (500 g) was
extracted with methanol at room temperature for three weeks with
shaking and stirring. Combined methanolic extracts were evap-
orated to dryness under reduced pressure below 40 ◦C and then
dissolved in distilled water and subjected to solvent–solvent frac-
tionation.
B. monosperma: Methanolic extract obtained was fractionated
with petroleum ether, benzene, chloroform and acetone in the
order of their increasing polarity to obtain respective fractions
(Sharma and Deshwal, 2011).
B. variegata: Methanolic extract was fractionated with hexane,
ethyl acetate and n-butanol in the order of their increasing polarity
to obtain respective fractions (Silva et al., 2008).
O. gratissimum: Methanolic extract was fractionated with hexane,
dichloromethane and ethyl acetate in the order of their increasing
polarity to obtain respective fractions (Chattopadhyay, 2003).
Each fraction was concentrated to dryness under reduced pres-
sure and below (40–50 ◦C) on a rotary evaporator to give acetone
fraction of B. monosperma [yield 9.4%, w/w], ethyl acetate fraction
[yield 2.2%, w/w]  and n-butanol fraction [yield 5.0%, w/w] of B.
variegate and dichloromethane fraction [yield 4.2% w/w] and ethyl
acetate fraction [yield 4.8%, w/w]  of O. gratissimum, respectively.
Establishment of qualitative and quantitative phytoproﬁle of
fractioned extracts
Qualitative phytochemical analysis
Each fraction was  subjected to various qualitative chemical tests
using reported methods to determine the presence or absence of
metabolites viz., alkaloids, tannins, ﬂavonoid, steroid, terpenoids
and phenolic compounds etc. (Khandelwal, 2001).
Chemical test for ﬂavonoids. Chemical tests were performed for
ﬂavonoids according to Macdonald (Macdonald et al., 2010).
Quantitative phytochemical analysis
Determination of total phenols. Each sample was mixed with 1 ml
Folin-Ciocalteu reagent and 0.8 ml  of 7.5% Na2CO3. The resultant
mixture was evaluated at 765 nm after 2 h at room temperature.
The mean of three readings was  used and the total phenolic content
was expressed in milligram of gallic acid equivalents/1 g extract.
The coefﬁcient of determination was found to be r2 = 0.992 (Yuvaraj
et al., 2011).
Determination of total ﬂavonoids. Standard quercetin was used to
create the calibration curve [0.04, 0.02, 0.0025 and 0.00125 mg/ml
in 80% ethanol (v/v)]. The standard solutions and test samples
(0.5 ml)  of each fraction was  mixed with 1.5 ml  of 95% ethanol
(v/v), 0.1 ml  of 10% aluminum chloride (w/v), 0.1 ml of 1 mol/l
sodium acetate and 2.8 ml  water. The volume of 10% aluminum
chloride was substituted by the same volume of distilled water in
the blank. After incubation at room temperature for 30 min, the
absorbance of the reaction mixture of each sample and standard
solution was  measured at 415 nm.  The mean of three readings was
used and the total ﬂavonoid content was expressed in milligram of
quercetin equivalents/1 g extract. The coefﬁcient of determination
was r2 = 0.99020 (Kosalec et al., 2004).
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n vivo hepatoprotective activity of selected ﬂavonoid fractions of
. monosperma, B. variegate and O. gratissimum against
aracetamol-induced toxicity
est animals
Male Wistar rats (125–175 g) were used for determination of
aximum tolerable dose and evaluation of hepatoprotective activ-
ty of ﬂavonoid rich fractions of B. monosperma, B. variegate and O.
ratissimum. The animals were housed in polypropylene cages at
5 ± 1 ◦C with the relative humidity of 55 ± 5% less than 12/12 h
ight/dark cycles. They were received a standard chow and water
d libitum during experimentation. The food was withdrawn on the
ay before the experiment, but free access of water was allowed.
 minimum of six animals was used in each group. Throughout
he experiments, animals were treated according to the suggested
nternational ethical guidelines for the maintenance of laboratory
nimals. The study protocol was approved by the Institutional Ani-
al  Ethics Committee, according to the regulation of committee for
he purpose of control and supervision of experiments on animals
MPC 1007: dated: 30/01/2010).
reparation and administration of test samples
The approved IAEC method was adopted for screening of hep-
toprotective activity. Dried fractions were suspended in 1% CMC
olution before oral administration to animals. Animals were
ivided into ﬁve groups of six rats each were used for the study.
roup 1 and 2 received normal saline (1 ml/kg orally) for seven
ays. Groups 3, 4, 5, 6, 7 and 8 received 100 mg/kg bw dose of
ilymarin, acetone fraction of B. monosperma, ethyl acetate and n-
utanol fractions of B. variegata and dichloromethane and ethyl
cetate fractions of O. gratissimum at 100 mg/kg of each orally, once
 day for seven days. On the ﬁfth day, after the administration
f the respective treatments, all the animals in groups 2, 3, 4, 5,
, 7 and 8th were administered paracetamol (PCM) 2 g/kg orally.
n the seventh day, the blood samples were collected via orbital
inus puncture for the estimation of biochemical marker enzymes.
hen the liver was carefully isolated and cleaned off extraneous
issue and preserved in 10% neutral formalin and then subjected to
istopathological studies (Parasuraman et al., 2010; Puratchikody
t al., 2006).
ssessment of biochemical parameters of liver
The enzymatic parameters of serum like serum glutamate
yruvate transaminase (SGPT), serum glutamate oxaloacetate
ransaminase (SGOT) and serum alkaline phosphatase (ALP) and
on-enzymatic parameter like total bilirubin (TB) were assayed
ccording to standard methods (Varley et al., 1994).
tatistical analysis
The outcomes are shown as mean ± S.E.M. (n = 6). Statistical sig-
iﬁcance was determined by one-way analysis of variance with
 < 0.01 and p < 0.05 considered signiﬁcant followed by Dunnett
ultiple Comparisons Test. The analysis was performed by Graph
ad InStat software.
esults
hytochemical screeningPreliminary phytochemical screening of alcoholic extract and its
ractions showed the presence of ﬂavonoids, steroids, terpenoids,
annins and phenolic compounds. The chemical test analysis
emonstrated that acetone fraction of B. monosperma, ethyl acetatemacognosia 25 (2015) 485–490 487
fraction and n-butanol fraction of B. variegata, dichloromethane and
ethyl acetate fractions of O. gratissimum were rich in phenolic com-
pounds. The phenolic content in B. monosperma (acetone fraction),
B. variegate (ethyl acetate and n-butanol fractions) and O. gratissi-
mum (dichloromethane and ethyl acetate fractions) were found to
be 452 ± 1.6, 712.4 ± 2.4, 442.5 ± 1.1, 735 ± 2.1 and 1365 ± 1.4 mg
gallic acid/1 g fraction respectively. The ﬂavonoid content in B.
monosperma (acetone fraction), B. variegata (ethyl acetate and n-
butanol fractions) and O. gratissimum (dichloromethane and ethyl
acetate fractions) were found to be 251 ± 1.8, 417 ± 2.2, 227 ± 3.2,
394.5 ± 2.4 and 717 ± 5.2 mg  quercetin/1 g fraction respectively.
The phenol and ﬂavonoid contents are responsible for hepatopro-
tective activity; hence these solvent fractions were taken for further
work.
Evaluation of hepatoprotective activity
From the effects of acute toxicity study by previously published
literature, 2000 mg/kg was  considered as maximum tolerable dose
of alcoholic extract of B. monosperma (Muralidhar et al., 2011), B.
variegata (Balamurugan and Muralidharan, 2010) and O. gratissi-
mum (Okoli et al., 2010). 1/20th of this dose was  considered as an
experimental dose for subsequent hepatoprotective studies. The
effective dose of each fraction was decided on the basis of previ-
ously published reports, i.e.  100 mg/kg of body weight.
Paracetamol has enhanced the levels of SGPT, SGOT, ALP and
total bilirubin. The results indicated that the ﬂavonoid rich frac-
tions of B. monosperma, B. variegata and O. gratissimum signiﬁcantly
reduced the elevated levels of SGPT, SGOT, ALP and bilirubin when
compared to paracetamol treated group. The results are shown in
Figs. 1 and 2.
Histopathological examination of the liver sections conﬁrmed
that the normal liver architecture was  damaged with paracetamol
administration. However, pretreatment of fractions of alcoholic
extracts of B. monosperma, B. vareigata and O. gratissimum at
100 mg/kg dose, signiﬁcantly reduced the severity of histopatho-
logical injury (compared with the paracetamol group). The results
of the biochemical tests and histopathological observations suggest
that 100 mg/kg of each fraction is effective against liver toxic-
ity. Rats treated with each ﬂavonoid fraction of B. monosperma,
B. vareigata and O. gratissimum showed noticeable improvement
in histopathological parameters. Thus, each fraction is considered
as prominent on paracetamol-induced liver damage. Moreover,
at necropsy, livers of rats treated with paracetamol appeared
degeneration in hepatocytes, hepatic cell injury, focal necrosis, con-
gestion in central vein, vascular swelling, kupffer cell proliferation.
Furthermore, no gross pathological ﬁndings were noted in the liv-
ers of the other groups of rats. The results are shown in Table 1 and
Fig. 3.
Discussion
Because B. monosperma, B. vareigata and O. gratissimum are
widely used in folk medicine for the treatment of liver dis-
eases, we investigated the hepatoprotective activity of the
ﬂavonoid rich fractions of each plant using two paraceta-
mol  induced liver toxicity models. Several mechanisms may
be linked up with the damage done to the liver by different
hepatotoxinsin. In the paracetamol model, the drug is sup-
posed to be eliminated mainly assulfate and glucuronide. Just
a modest quantity (5%) is metabolized via the cytochrome
P450 enzyme system to the alkylating metabolite, N-acetyl-p-
benzoquinoneimine (NAPQI), which is responsible for the toxic
side effects of paracetamol. Yet, upon administration of toxic doses
of paracetamol, the sulfation and glucuronidation routes become
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Fig. 1. Effect of all ﬂavonoid fractions obtained from the alcoholic extract of Butea monosperma, Bauhinia variegate and Ocimum gratissimum on SGOT, SGPT and ALP (U/L) in
paracetamol induced hepatic injury in rats.
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
PCM
treated
Control Silymarin
treated
AcO fraction
of BM
treated
EtOAc
fraction of
 BV treated
n-butanol
fraction of
BV treated
DCM
fraction of
OG treated
EtOAc
fraction of
OG treated
Total bilirubin (mg/dl)
Direct bilirubin (mg/dl)
Treatment groups
Le
ve
l o
f b
io
ch
em
ica
l p
ar
am
et
er
s
Fig. 2. Effect of all ﬂavonoid fractions obtained from the alcoholic extract of Butea monosperma, Bauhinia variegate and Ocimum gratissimum on total bilirubin (mg/dl) in
paracetamol induced hepatic injury in rats.
Table 1
Histopathological changes in the liver of rats.
Microscopic observation Control Paracetamol Silymarin Acetone
fr. of BM
Ethyl acetate
fraction of BV
n-Butanol
fraction of BV
Dichloromethane
fraction of OG
Ethyl acetate
fraction of OG
Degeneration in hepatocytes + +++ ++ ++ ++ ++ ++ ++
Hepatic cell injury Ø +++ ++ +⊥ +⊥ +⊥ +⊥ +⊥
Focal  necrosis Ø +++ Ø +⊥ +⊥ +⊥ +⊥ +⊥
Congestion in central vein + +++ + +⊥ +⊥ +⊥ +⊥ +⊥
Vascular swelling + +++ + ++ +⊥ +⊥ +⊥ +⊥
Ø
s
d
N
p
a
d
a
l
m
i
tKupffer cell proliferation Ø ++ + ++ 
, absent; ⊥, few; + mild; ++, moderate; +++, severe; ++++, extremely severe.
aturated, and thus, higher part of paracetamol molecules are oxi-
ized to highly reactive NAPQI. Higher dose of paracetamol and
APQI can alkylate and oxidize intracellular glutathione (GSH) and
rotein thiol groups, which result in the depletion of liver GSH pool
nd subsequently lead to increased lipid peroxidation and liver
amage (Akah and Odo, 2010; Dong et al., 2000).
In this study, ﬂavonoid fraction of B. monosperma, B. vareigata
nd O. gratissimum demonstrated signiﬁcant (p < 0.01 and p < 0.05)
iver protection against the hepatic injuries caused by the paraceta-
ol. It is apparent that several phytoconstituents have the power to
nduce microsomal enzymes either by accelerating the excretion of
he hepatotoxin or by suppression of lipidperoxidation induced by+⊥ +⊥ +⊥ ++
it (Mehta et al., 1999). Phytoconstituents like ﬂavonoids (Baek et al.,
1996; Pandit et al., 2004) andtriterpenes (ursolic acid) (Xiong et al.,
2003) are known to possess hepatoprotective activities. Liver pro-
tective herbal drugs contain a variety of chemical constituents like
phenols and ﬂavonoids (Sharma et al., 1991). There is every possi-
bility that these active principles alone or in combination may  be
responsible for the hepatoprotection demonstrated in this work.
Recently, total ﬂavonoids were reported to protect animals from
liver injury and liver ﬁbrosis (Singab et al., 2005; Yuan et al., 2008;
Zhong et al., 2007). The protective effect exhibited by the ﬂavonoid
fractions could be due to the protection of hepatic drug metaboliz-
ing enzymes. It is therefore concluded that the ﬂavonoid fraction
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Fig. 3. The photomicrographs of liver section from rats: (A) received saline 0.5 ml  as a normal control group (10 × 10); (B) paracetamol (2 g/kg) (10 × 10); (C) silymarin
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B100  mg/kg bw.) + paracetamol (10 × 10); (D) acetone fraction of BM (100 mg/kg 
-butanol fraction of BV (100 mg/kg bw.) + paracetamol; (G) dichloromethane frac
100  mg/kg bw.) + paracetamol.
f B. monosperma, B. vareigata and O. gratissimum have promising
epatoprotective potentials.
onclusions
The hepatoprotective effect of ﬂavonoid rich fractions of B.
onosperma, B. vareigata and O. gratissimum may  be attributed due
o the reduced SGPT, SGOT, ALP and bilirubin and improved defense
f the hepatocytes against the paracetamol. The histopathologi-
al studies also conﬁrm the action of the drug. Thus the study
cientiﬁcally supports the usage of ﬂavonoid rich fractions of B.
onosperma, B. vareigata and O. gratissimum for treatment of liver
isorders and as a tonic. To elucidate the exact mechanism respon-
ible for the hepatoprotective effects of ﬂavonoid rich fractions of B.
onosperma, B. vareigata and O. gratissimum, further experiments
re being conducted in our laboratory.
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